期刊文献+

眼恶性肿瘤患者凝血功能检测的临床意义 被引量:2

Meaning of the coagulative function in serum for eye malignant tumor diagnosis and evaluation
下载PDF
导出
摘要 目的:探讨检测血浆中D-二聚体(D-D)、纤维蛋白原(Fib)及其降解产物(FDP)的水平在眼恶性肿瘤诊断和病情评估方面的应用及临床意义。方法:选择我院眼科确诊为眼恶性肿瘤患者67例(恶性肿瘤组),其中眼恶性肿瘤无转移组(44例)、眼恶性肿瘤转移组(23例);同期收治的眼良性肿瘤患者46例(良性肿瘤组);本院同期健康体检者30例(健康对照组)。测定血浆中D-D、Fib、FDP水平并进行比较。结果:眼恶性肿瘤患者血浆中D-D、Fib、FDP水平显著高于眼良性肿瘤组、健康对照组(P<0.05),其中恶性肿瘤转移组患者血浆中D-D、Fib、FDP水平又显著高于恶性肿瘤无转移组(P<0.05)。而眼良性肿瘤与健康对照组血浆中D-D、Fib、FDP水平差异无统计学意义(P>0.05)。各组D-D含量分布差异有统计学意义(P<0.05)。结论:血浆中D-D、Fib、FDP水平的检测对于眼良恶性肿瘤的判断及肿瘤的进展及预后有重要的临床意义。 AIM : To explore the meaning of the level of D-dimer (D- D), fibrinogen (Fib) and fibrin degradation products (FDP) in serum for eye malignant tumor diagnosis and evaluation. ~ METHODS: Sixty-seven patients with eye malignant tumor (malignant tumor group) in our hospital were selected, among which, 44 as malignant tumor without metastasis group, 23 as malignant tumor with metastasis group; 46 patients were selected with eye benign tumor (benign tumor group) during the same time period; 30 healthy people visited our hospital for regular physical examination was elected simultaneously as the healthy control group. The level of D-D, Fib and FDP were detected in serum. RESULTS: The D-D, Fib and FDP level in eye malignant tumor group was significantly higher than those in either the eye benign tumor group or the healthy control group (P〈 0.01 ), malignant tumor with metastasis group had the significant higher level of D-D, Fib and FDP than those of malignant tumor without metastasis group ( P〈 0.05~). There was no significant difference statistically between the eye benign tumor group and healthy control group of the serum level of D-D, Fib and FDP (P〉0.05). There was significant difference of D-D level distribution among each group ( P〈0.05). CONCLUSION- To detect the level of D-D, Fib and FDP in serum can help with differentiation the tumor from benign to malignancy, analysis the progression of tumor and prognosis.
出处 《国际眼科杂志》 CAS 2013年第11期2237-2239,共3页 International Eye Science
基金 国家自然科学基金项目(No.81273605)~~
关键词 D-二聚体 纤维蛋白原 纤维蛋白原降解产物 恶性肿瘤 D-dimer fibrinogen fibrin degradationproducts eye malignant tumor
  • 相关文献

参考文献5

二级参考文献47

  • 1王明山,杨丽红,潘景业,王霄霞,陆红,吕美艳,陈少贤,谢于鹏.晚期肺癌患者化疗过程中抗凝血酶和纤溶功能的变化及意义[J].中国肺癌杂志,2007,10(3):226-228. 被引量:13
  • 2胡志德,王璐璐,赫慧楠.5种恶性肿瘤患者血浆D二聚体阳性检出率比较[J].血栓与止血学,2006,12(6):262-263. 被引量:22
  • 3李宏波,徐爱芳.D-D二聚体检测在肝病诊治中的意义[J].浙江预防医学,2007,19(6):85-86. 被引量:5
  • 4闫华,赵崇高,江涛.恶性肿瘤患者血浆D-二聚体和纤维蛋白原水平的检测与分析[J].河南科技大学学报(医学版),2007,25(1):27-28. 被引量:16
  • 5Parkin D M, Bray F, Ferlay J, et al. Global cancer statistics, 2002[J]. CA Cancer J Clin, 2005, 55(2) : 74-108.
  • 6Slamon D J, Clark G M,Wong S G, et al. Human Breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene[J]. Science, 1987, 235(4785): 177-182.
  • 7Johnston J B, Navaramam S, Pitz M W, et al. Targeting the EGFR pathway for cancer therapy[J].Curr Med Chem, 2006, 13(29) : 3483-3492.
  • 8Montemurro F, Donadio M, Clavarezza M, et al. Outcome of patients with HER2-positive advanced breast cancer progressing during trastuzumah-based therapy [J]. Oncologist, 2006, 11 (4):318-324.
  • 9Finn R S, Gagnon R, Di Leo A, et al. Prognostic and predictive value of HER2 extracellular domain in metastatic breast cancer treated with lapatinib and paclitaxel in a randomized phase Ⅲ study[J]. J Clin Oncol, 2009, 27(33): 5552-5558.
  • 10Geyer C E, Forster J, Lindquist D, et al. Lapatinib plus capecit abine for HER2-positive advanced breast cancer[J]. N Engl J Med, 2007, 355(26): 2733-2743.

共引文献179

同被引文献32

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部